title: An antioxidant extract of tropical lichen, Parmotrema reticulatum, induces cell cycle arrest and apoptosis in breast carcinoma cell line MCF-7.
abstract: This report highlights the phytochemical analysis, antioxidant potential and anticancer activity against breast carcinoma of 70% methanolic extract of lichen, Parmotrema reticulatum (PRME). Phytochemical analysis of PRME confirms the presence of various phytoconstituents like alkaloids, carbohydrates, flavonoids, glycosides, phenols, saponins, tannins, anthraquinones, and ascorbic acid; among which alkaloids, phenols and flavonoids are found in abundant amount. High performance liquid chromatography (HPLC) analysis of PRME revealed the presence of catechin, purpurin, tannic acid and reserpine. Antioxidant activity was evaluated by nine separate methods. PRME showed excellent hydroxyl and hypochlorous radical scavenging as well as moderate DPPH, superoxide, singlet oxygen, nitric oxide and peroxynitrite scavenging activity. Cytotoxicity of PRME was tested against breast carcinoma (MCF-7), lung carcinoma (A549) and normal lung fibroblast (WI-38) using WST-1 method. PRME was found cytotoxic against MCF-7 cells with an IC50 value 130.03 ± 3.11 µg/ml while negligible cytotoxicity was observed on A549 and WI-38 cells. Further flow cytometric study showed that PRME halted the MCF-7 cells in S and G2/M phases and induces apoptosis in dose as well as time dependent manner. Cell cycle arrest was associated with downregulation of cyclin B1, Cdk-2 and Cdc25C as well as slight decrease in the expression of Cdk-1 and cyclin A1 with subsequent upregulation of p53 and p21. Moreover PRME induced Bax and inhibited Bcl-2 expression, which results in increasing Bax/Bcl-2 ratio and activation of caspase cascade. This ultimately leads to PARP degradation and induces apoptosis in MCF-7 cells. It can be hypothesised from the current study that the antioxidant and anticancer potential of the PRME may reside in the phytoconstitutents present in it and therefore, PRME may be used as a possible source of natural antioxidant that may be developed to an anticancer agent.
authors.affiliation: Division of Molecular Medicine, Bose Institute, Kolkata, India.
authors.forename: Nikhil Baban
authors.initials: NB
authors.lastname: Ghate
authors.affiliation: Division of Molecular Medicine, Bose Institute, Kolkata, India.
authors.forename: Dipankar
authors.initials: D
authors.lastname: Chaudhuri
authors.affiliation: Division of Molecular Medicine, Bose Institute, Kolkata, India.
authors.forename: Rhitajit
authors.initials: R
authors.lastname: Sarkar
authors.affiliation: Department of Ecology and Environmental Science, Assam University, Silchar, Assam, India.
authors.forename: Albert L
authors.initials: AL
authors.lastname: Sajem
authors.affiliation: Division of Molecular Medicine, Bose Institute, Kolkata, India.
authors.forename: Sourav
authors.initials: S
authors.lastname: Panja
authors.affiliation: Department of Ecology and Environmental Science, Assam University, Silchar, Assam, India.
authors.forename: Jayashree
authors.initials: J
authors.lastname: Rout
authors.affiliation: Division of Molecular Medicine, Bose Institute, Kolkata, India.
authors.forename: Nripendranath
authors.initials: N
authors.lastname: Mandal
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism / Q000473:pathology*; D000975:Antioxidants / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D059447:Cell Cycle Checkpoints / Q000187:drug effects*; D049109:Cell Proliferation; D005260:Female; D006801:Humans; D008011:Lichens; D061986:MCF-7 Cells; D010936:Plant Extracts / Q000494:pharmacology*; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: D000975:Antioxidants; D010936:Plant Extracts; D017382:Reactive Oxygen Species